Traws Pharma Inc. (TRAW) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Traws Pharma Inc.

    NASDAQ: TRAW · Real-Time Price · USD
    1.85
    -0.03 (-1.60%)
    At close: Sep 26, 2025, 3:57 PM
    1.89
    2.06%
    After-hours: Sep 26, 2025, 07:04 PM EDT

    Traws Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 21.34M 20.82M 38.76M 55.07M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 1K 1K 1K 10K
    Receivables
    		 1.76M 18K 29K 28K
    Inventory
    		 n/a n/a 521K 297K
    Other Current Assets
    		 178K 401K -481K -262K
    Total Current Assets
    		 24.95M 22.66M 39.35M 55.43M
    Property-Plant & Equipment
    		 10K 22K 24K 38K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 11K 23K 25K 48K
    Total Assets
    		 24.96M 22.68M 39.37M 55.48M
    Account Payables
    		 8.19M 5.62M 3.86M 2.76M
    Deferred Revenue
    		 226K 226K 226K 226K
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 265K 2.37M 1.19M 1.92M
    Total Current Liabilities
    		 11.53M 9.22M 8.05M 6.12M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 42.49M n/a n/a n/a
    Total Long-Term Liabilities
    		 45.06M 2.79M 3.02M 3.24M
    Total Liabilities
    		 56.59M 12.01M 11.06M 9.36M
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 -31.63M 10.67M 28.31M 46.12M
    Book Value Per Share
    		 -20.37 12.71 33.85 68.50
    Common Stock
    		 36K 210K 209K 209K
    Retained Earnings
    		 -649.15M -482.63M -463.68M -444.72M
    Comprehensive Income
    		 -42K -23K -33K -14K
    Shareholders Equity
    		 -31.63M 10.67M 28.31M 46.12M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist